Medicare patients who have access to telehealth services and medications for opioid use disorder have lower risk of fatal drug overdose, according to a study reported yesterday in JAMA Psychiatry.

“The results of this study add to the growing research documenting the benefits of expanding the use of telehealth services for people with opioid use disorder, as well as the need to improve retention and access to medication treatment for opioid use disorder,” said Christopher Jones, lead author and director of the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention. “The findings from this collaborative study also highlight the importance of working across agencies to identify successful strategies to address and get ahead of the constantly evolving overdose crisis.”

Related News Articles

Headline
Hospitals may continue to bill through calendar year 2023 for certain outpatient physical therapy, occupational therapy, speech language pathology services,…
Headline
Telehealth Access for America, an AHA-supported campaign to protect patient access to critical telehealth services, urged Congress to make permanent certain…
Headline
As urged by the AHA, the Drug Enforcement Administration and Substance Abuse and Mental Health Services Administration released a temporary rule …
Headline
Pregnant people with opioid use disorder are more likely to receive buprenorphine (a recommended treatment) if they are older, white and have public insurance…
Headline
HIPAA enforcement discretion implemented for the COVID-19 public health emergency will expire with the end of the PHE on May 11, but covered health care…
Headline
New results from an ongoing clinical trial provide strong evidence that emergency departments can safely start buprenorphine treatment for opioid use disorder…